The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Epilim Chrono 200mg Prolonged Release Tablets

200 milligram(s) Prolonged-release tablet

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/150/010

Main Information

Trade NameEpilim Chrono 200mg Prolonged Release Tablets
Active SubstancesSODIUM VALPROATE
Valproic acid
Strength200 milligram(s)
Dosage FormProlonged-release tablet
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/150/010

Group Information

ATC CodeN03AG Fatty acid derivatives
N03AG01 valproic acid

Status

Authorised/WithdrawnAuthorised
Licence Issued24/08/1992
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back